- Direction
- Unknown
- Own history
- —
- Peers
- 50th
- Persistence
- TRANSIENT
· In Vitro & In Vivo Diagnostic Substances
RESEARCH SNAPSHOTVOLITIONRX LTD's latest supported as-filed period reports revenue of $398,657. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
Separate current dimensions—not a universal score or investment ranking.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.debt_to_revenue
Raw value 1768.90% · OPTIONAL
Level · gp.fundamentals.capex_revenue_ratio
Raw value 0.45% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -1294.26% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value -1.97% · CORE
Level · gp.fundamentals.operating_margin
Raw value -1042.50% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 451.68% · OPTIONAL
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 2 independently calculated changes: Cash & equivalents increased 21.7%; Operating cash flow increased 17.6%.
2 evidence-backed componentsStock-based compensation changed -70.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
VNRX · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001477932-26-006470SEC ↗4Oct 23, 2026Period Oct 21, 20260001477932-26-006439SEC ↗4Sep 30, 2026Period Sep 28, 20260001477932-26-005936SEC ↗4Sep 30, 2026Period Sep 28, 20260001477932-26-005935SEC ↗8-KSep 25, 2026Period Sep 22, 20260001477932-26-005804SEC ↗8-KSep 15, 2026Period Sep 9, 20260001477932-26-005620SEC ↗8-KSep 14, 2026Period Sep 11, 20260001477932-26-005578SEC ↗8-KTransaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Oct 21, 2026Filed Oct 23, 2026 | Batchelor Ann-LouiseGroup Chief Marketing Officer | Grant Or AwardDirect | 12,000 | $0 | $0 | Form 4 ↗ |
| Sep 28, 2026Filed Sep 30, 2026 | Forterre GaelChief Commercial Officer | Tax WithholdingDirect | 284 | $0 | $72 | Form 4 ↗ |
| Mar 17, 2026Filed Mar 19, 2026 | Forterre GaelChief Commercial Officer | Tax WithholdingDirect | 5,251 | $0 | $998 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Level · gp.fundamentals.sbc_revenue_ratio
Raw value 59.70% · OPTIONAL
Operating income changed +34.0% from the comparable as-filed period.
Shares outstanding changed -87.3% from the comparable as-filed period. The change ranks at the 75th percentile of 8 prior comparable changes.
Operating margin changed +50606 basis points from the comparable as-filed period.
Capital expenditure changed -97.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Research & development changed -33.8% from the comparable as-filed period.
Cash & equivalents changed +21.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001477932-26-005359